Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Nanobiotix
company
About
Nanobiotix is a nanomedicine company developing novel therapeutics for the local treatment of cancer.
- 101 - 250
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- €16M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2003
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€37M
Nanobiotix has raised a total of
€37M
in funding over 2 rounds. Their latest funding was raised on
Mar 4, 2019 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 4, 2019 | Post-IPO Debt | €14M | 1 |
European Investment Bank
|
— | Detail |
| Oct 17, 2018 | Post-IPO Debt | €16M | 1 |
European Investment Bank
|
— | Detail |
| May 5, 2010 | Series C | €7M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
4
Nanobiotix is funded by 4 investors.
European Investment Bank
and Amorçage Rhône Alpes
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Investment Bank
|
Yes | Post-IPO Debt |
|
|
— | Series C |
|
|
— | Series C |
Apicap
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
